Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS2 | Q8NHU3 | 2/20 | 0.46 |
| ▸ | LRRK2 | Q5S007 | 7/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.45 |
| ▸ | MTOR | P42345 | 2/20 | 0.45 |
| ▸ | BRAF | P15056 | 5/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | KIT | P10721 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20509677 | 1.00 | SGMS2 (0.46) | SGMS2LRRK2PIK3CAMTORBRAF | |
| SCHEMBL30779602 | 0.88 | SGMS2 (0.47) | SGMS2LRRK2BRAFMEN1KMT2A | |
| SCHEMBL21644625 | 0.88 | SGMS2 (0.47) | SGMS2LRRK2BRAFMEN1KMT2A | |
| SCHEMBL21644716 | 0.86 | KDR (0.52) | SGMS2LRRK2MEN1KMT2A | |
| SCHEMBL30779598 | 0.86 | KDR (0.52) | SGMS2LRRK2MEN1KMT2A | |
| SCHEMBL21644687 | 0.83 | SGMS2 (0.62) | SGMS2LRRK2MEN1KMT2AGAA | |
| SCHEMBL30779582 | 0.83 | SGMS2 (0.62) | SGMS2LRRK2MEN1KMT2AGAA | |
| SCHEMBL21644617 | 0.82 | LRRK2 (0.44) | SGMS2LRRK2MEN1KMT2AGAA | |
| SCHEMBL21644608 | 0.82 | LRRK2 (0.46) | SGMS2LRRK2MEN1KMT2AGAA | |
| SCHEMBL30779637 | 0.82 | LRRK2 (0.46) | SGMS2LRRK2MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111164074-B | Heat shock protein 90 inhibitors | 台北医学大学 | 2024-02-02 | — | — | CN | disclosed |